AI is used in healthcare today to draft notes, read images, review pathology slides, screen eyes, find polyps, triage strokes, flag sepsis risk, route patients, handle administrative work, and support drug discovery. Each example solves a different job, so each one needs different proof, safeguards, and accountable people.
| Use | What the AI does | What to verify |
|---|---|---|
| 1. Clinical documentation | Drafts a note from the visit | Correction time, retention, and clinician review |
| 2. Medical imaging | Flags or characterizes a finding | Exact authorized use and local performance |
| 3. Digital pathology | Marks or measures features on a slide | Scanner fit, specimen fit, and pathologist review |
| 4. Diabetic eye screening | Produces a narrow screening result | Authorized population, image quality, and referral follow-through |
| 5. Colonoscopy polyp detection | Highlights a possible polyp during the procedure | False alerts, withdrawal practice, and measured detection |
| 6. Stroke triage | Prioritizes a suspected stroke scan or alert | Time saved, missed cases, and action after the alert |
| 7. Sepsis and deterioration | Estimates future clinical risk | External validation, alert burden, and workflow response |
| 8. Patient access | Routes scheduling, intake, messages, or calls | Completion, escalation, accessibility, and wrong-route rates |
| 9. Administrative work | Supports coding, authorization, claims, and payer communication | Denials, rework, exceptions, and net financial result |
| 10. Drug discovery | Finds patterns, targets, or candidate molecules | Laboratory or clinical confirmation beyond the AI output |
1. Drafting Clinical Notes
Ambient documentation systems listen during a visit and draft a structured note for the clinician to review. The immediate benefit is less typing and less work after clinic. The risk is treating a fluent draft as a finished record. A useful evaluation measures correction time, missed facts, unsupported statements, specialty fit, and what happens to the audio after the note is created. The ambient AI evidence library separates independent studies from vendor claims, while the company directory shows the main vendors in this category.
2. Reading Images and Supporting Diagnosis
AI can mark a possible finding, sharpen an image, measure anatomy, or support a narrow diagnostic decision. Those are different jobs. The FDA says more than 1,600 AI-enabled medical devices had been authorized for marketing in the United States by September 2026, but an authorization applies to a specific intended use rather than every claim a product can make. Use the source-linked FDA directory to inspect clearance records, the imaging company directory to compare vendors, and the breast screening evidence to see how performance is studied.
3. Reviewing Digital Pathology Slides
Digital pathology AI can mark regions on a whole-slide image, count cells, measure features, or help a pathologist prioritize review. The result depends on the tissue, stain, scanner, image quality, and clinical question. A model that performs well on one setup may not carry that result into another laboratory. The digital pathology evidence library keeps those study details beside the claims.
4. Screening for Diabetic Retinopathy
Some authorized systems can produce a narrow screening result from retinal images without a specialist reading every image first. That does not make the whole care decision autonomous. Image quality, the approved patient population, referral completion, and access to follow-up care still decide whether screening helps. The diabetic retinopathy evidence separates diagnostic accuracy from what happened after the result.
5. Finding Polyps During Colonoscopy
Computer-aided detection can highlight a possible polyp while the endoscopist is examining the colon. The alert may help draw attention to a finding, but it does not remove the need for technique, judgment, removal, pathology, or follow-up. The colonoscopy evidence library shows randomized trials and reviews, including the difference between finding more lesions and improving a patient outcome.
6. Triaging Suspected Stroke
Stroke triage AI can flag a suspected large-vessel occlusion, move a scan up a worklist, or alert a specialist. Speed matters, but only when the alert reaches the right person and changes treatment quickly enough to matter. Review the stroke triage evidence for measured workflow and clinical results, then use the neurology clearance directory to inspect authorized uses.
7. Flagging Sepsis and Deterioration Risk
Predictive systems estimate the chance of sepsis, deterioration, readmission, or another future event and surface that estimate to a care team. The score is only the first link in the chain. Someone must receive it, understand it, decide whether to act, and have enough time and authority to change care. Review the sepsis and deterioration evidence for the difference between retrospective accuracy and a measured result after deployment.
8. Helping Patients Reach the Right Service
Patient-facing AI now handles parts of intake, scheduling, referral routing, call-center work, translation, and message triage. The best measure is not how many conversations the system completed. It is whether the patient reached the correct service with less delay and could reach a person when the request was urgent, unusual, or misunderstood. The patient access company group shows how vendors divide this work, and the patient discovery library covers the step before a patient contacts the health system.
9. Automating Revenue Cycle and Administrative Work
AI is also used for coding support, prior authorization, benefit verification, claim review, denial prevention, and payer communication. These uses may carry less direct clinical risk, but they can still expose protected health information and create expensive mistakes at scale. Count denials, rework, audit findings, days in accounts receivable, net collections, and the staff time still needed around exceptions. The revenue cycle company group and healthcare AI ROI report provide the buyer view.
10. Supporting Research and Drug Discovery
Researchers use AI to search scientific literature, identify biological targets, design candidate molecules, analyze images and molecular data, and choose experiments. A model can narrow a huge field faster, but the result still has to survive laboratory testing, clinical trials, and regulatory review. NIH-backed work on AI-designed antibiotic candidates is one current example of the model proposing what scientists should test next rather than replacing the test. The life sciences company group separates platform businesses, research partners, and drug developers with their own pipelines.
What to Check Before You Trust a Healthcare AI Claim
- Define the exact job and the decision the AI can influence.
- Ask for evidence from a population and workflow that resemble your own.
- Confirm the exact regulatory status for that use, not for the product family in general.
- Map every data source, processor, retention period, and model-training use.
- Measure the full workflow after launch, including exceptions, rework, alert burden, and the result that matters to patients or the business.
The common thread is simple: AI produces a draft, signal, score, recommendation, or shortlist. Healthcare still needs a named person or team responsible for checking it and acting on it. That is the difference between an impressive demonstration and a working system.